BioSmart바이오스마트
038460 · KOSDAQ · ₩038460 · 바이오스마트
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩11,650
vs the current price (₩2,495)
- Enterprise value
- ₩330B
- Equity value
- ₩294B
- WACC
- 6.0%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 367% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- To match today's price of ₩2,495, the model needs an operating margin of 2.0% every year (it uses 3.9%).
- In the projection, spending on equipment, software and working capital takes most or all of the after-tax operating profit, so free cash flow is thin. Companies that invest heavily often look like this until spending slows.
- Today's P/E is 4.7× against a typical 15.0× over the last 10 years.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩1,000
- −59.9%
- Base
- ₩11,650
- +366.9%
- Bull
- ₩33,597
- +1,246.6%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (3.9%).
Revenue growth
- 7.2%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (7.2% a year, annual reports), fading to 3% by year 5.
- 6.2%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (7.2% a year, annual reports), fading to 3% by year 5.
- 5.1%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (7.2% a year, annual reports), fading to 3% by year 5.
- 4.1%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (7.2% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (7.2% a year, annual reports), fading to 3% by year 5.
Business
- 3.9%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 1.3%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 3.3%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 15.7%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.11%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-28.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.07, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.61%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩563B
- Net debt (borrowings and leases − cash and deposits)
- ₩46B
- + Stakes and investments
- ₩58B
- Associates, long-term financial assets and deposits (book value)
- − Minority interests
- ₩47B
- Shares
- 25,274,542
- Share price
- ₩2,495
- Market cap
- ₩63B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩456B | ₩484B | ₩483B | ₩603B | ₩641B | ₩673B | ₩701B | ₩722B |
| Growth | 16.4% | 6.2% | −0.3% | 7.2% | 6.2% | 5.1% | 4.1% | 3.0% |
| EBIT | ₩10B | ₩20B | ₩23B | ₩24B | ₩25B | ₩26B | ₩27B | ₩28B |
| EBIT margin | 2.2% | 4.2% | 4.7% | 3.9% | 3.9% | 3.9% | 3.9% | 3.9% |
| After-tax EBIT | ₩7.3B | ₩15B | ₩16B | ₩17B | ₩18B | ₩19B | ₩20B | ₩20B |
| + Depreciation | ₩4.8B | ₩7.2B | ₩6.6B | ₩7.8B | ₩8.3B | ₩8.8B | ₩9.1B | ₩9.4B |
| − Capital spending | ₩4.9B | ₩8.7B | ₩34B | ₩20B | ₩21B | ₩22B | ₩23B | ₩24B |
| − Working capital | ₩16B | ₩17B | −₩2.2B | ₩6.4B | ₩5.9B | ₩5.1B | ₩4.3B | ₩3.3B |
| Free cash flow | −₩8.4B | −₩3.6B | −₩8.6B | −₩1.4B | −₩571M | ₩442M | ₩1.5B | ₩2.7B |
| Discount factor | — | — | — | 0.943 | 0.890 | 0.840 | 0.792 | 0.747 |
| Present value | — | — | — | −₩1.3B | −₩508M | ₩371M | ₩1.2B | ₩2B |
Terminal value ₩439B, worth ₩328B today: 99% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩5,938 a share)Now 0.42× | ₩3,0490.51× | ₩4,7860.81× | ₩7,3681.24× |
| Price / earnings (last 12 months: ₩534 a share)Now 4.68× | ₩3,0755.76× | ₩8,02115.0× | ₩22,64942.4× |
| P/E on run-rate earnings (Q2 2026 × 4: ₩167 a share)Now 15.0× | ₩9605.76× | ₩2,50315.0× | ₩7,06942.4× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 5.0% | ₩13,041 | ₩14,668 | ₩16,832 | ₩19,856 | ₩24,387 |
| 5.5% | ₩11,140 | ₩12,334 | ₩13,866 | ₩15,903 | ₩18,749 |
| 6.0% | ₩9,626 | ₩10,528 | ₩11,650 | ₩13,090 | ₩15,003 |
| 6.5% | ₩8,395 | ₩9,089 | ₩9,935 | ₩10,988 | ₩12,338 |
| 7.0% | ₩7,374 | ₩7,919 | ₩8,569 | ₩9,361 | ₩10,347 |
Now (TTM)
- Market cap
- ₩63B
- Enterprise value
- ₩105B
- P/E
- 4.7×
- P/B
- 0.4×
- P/S
- 0.1×
- EV/EBITDA
- 3.1×
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩3,900 | ₩3,080 | ₩3,425 | ₩3,330 | ₩5,710 |
| Market cap | ₩99B | ₩78B | ₩87B | ₩84B | ₩144B |
| P/E | 10.9× | 612.1× | 4.8× | 116.7× | 103.6× |
| P/B | 0.7× | 0.6× | 0.8× | 0.9× | 1.5× |
| P/S | 0.2× | 0.2× | 0.2× | 0.2× | 0.8× |
| EV/EBITDA | 4.8× | 4.2× | 9.4× | 7.4× | 14.8× |
| Dividend yield | 0.0% | — | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| BioSmart | 4.7× | 0.4× | 0.1× | 3.1× | 0.0% |
| Samsung Electro-Mechanics | 96.8× | 9.5× | 7.8× | — | 0.2% |
| Doosan | 39.2× | 5.5× | 0.7× | — | 0.4% |
| Hanwha Systems | 71.2× | 2.8× | 3.0× | — | 0.8% |
| LG Innotek | 13.1× | 1.4× | 0.4× | — | 0.5% |
| Isupetasys | 35.4× | 8.3× | 5.4× | — | 0.0% |
| Daeduck Electronics | 44.8× | 7.0× | 5.0× | — | 0.4% |
| Similar companies (median) | 42.0× | 6.3× | 4.0× | — | 0.4% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: BioSmart / 바이오스마트 / 038460 / KRX:038460
Source: KRX statistical information